期刊文献+

骨髓和脂肪来源的间充质干细胞免疫调节作用的比较 被引量:7

Comparison of immuno-modulatory properties between bone-marrow derived MSCs and adipose derived MSCs
下载PDF
导出
摘要 目的比较脂肪源间充质干细胞(AMSCs)和骨髓来源间充质干细胞(BMSCs)的免疫调节能力的差异。方法用流式细胞仪分析AMSCs和BMSCs的表型。通过MSCs和淋巴细胞共培养体系,检测MSCs对T细胞增殖、周期、活化、凋亡以及Th细胞分化的影响。结果表型分析结果显示AMSCs和BMSCs的表型基本一致。AMSCs和BMSCs都能抑制T细胞的增殖和早期活化,并在调节辅助性T细胞亚群的分化上作用类似。但在MSC对活化后T细胞的凋亡影响方面,BMSCs能够抑制活化T细胞的凋亡,而AMSC没有这种作用。结论 AMSCs和BMSCs对T淋巴细胞的影响基本类似,其对活化T细胞凋亡影响的差异还有待进一步的机制研究。 Objective To compare MSCs' immuno-modulatory property between bone-marrow derived and adipose derived MSCs. Methods Phenotype analysis of both MSCs populations was detected by flow-cytometry. To analyse immuno-modulatory effect of MSCs, proliferation, cell cycle, activation, apoptosis and Thl/Th2 balance were ana- lyzed after co-culturing lymphocytes and MSCs. Results Phenotype analysis showed that AMSCs had the similar ex- pression of markers with BMSCs. Both AMSCs and BMSCs could inhibit T cells proliferation and activation. Also MSCs' effect on Th cell differentiation into Thl or Th2 was similar between AMSCs and BMSCs. Nevertheless, BMSCs could suppress activated T cell apoptosis, while AMSCs could not. Conclusions AMSCs and BMSCs showed similar immuno-modulatroy effect on T lymphocytes, however the difference effect on activated T cell apop- tosis of the two cell populations is still unclear and the mechanism needs to explore.
出处 《基础医学与临床》 CSCD 北大核心 2012年第2期128-132,共5页 Basic and Clinical Medicine
基金 国家自然科学基金青年基金(30800429) "长江学者和创新团队发展计划"项目(IRT0909)
关键词 骨髓间充质干细胞 脂肪间充质干细胞 免疫调节 bone marrow derived MSCs adipose derived MSCs immuno-modulatory
  • 相关文献

参考文献14

  • 1Tse WT,Pendleton JD,Beyer WM,et al.Suppression ofallogeneic T-cell proliferation by human marrow stromalcells:implications in transplantation[J].Transplantation,2003,75:3893-3897.
  • 2Aggarwal S,Pittenger MF.Human mesenchymal stem cellsmodulate allogeneic immune cell responses[J].Blood,2005,105:1815-1822.
  • 3Glennie S,Soeiro I,Dyson PJ,et al.Bone marrow mesen-chymal stem cells induce division arrest anergy of activatedT cells [J].Blood,2005,105:2821-2827.
  • 4Corcione A,Benvenuto F,Ferretti E,et al.Human mesen-chymal stem cells modulate B-cell functions[J].Blood,2006,107:367-372.
  • 5Sotiropoulou PA,Perez SA,Gritzapis AD,et al.Interac-tions between human mesenchymal stem cells and naturalkiller cells [J].Stem Cells,2006,24:74-85.
  • 6Jiang XX,Zhang Y,Liu B et al.Human mesenchymal stemcells inhibit differentiation and function of monocyte-deriveddendritic cells[J].Blood,2005,105:4120-4126.
  • 7Bartholomew A,Sturgeon C,Siatskas M,et al.Mesenchy-mal stem cells suppress lymphocyte proliferation in vitro andprolong skin graft survival in vivo[J].Exp Hematol,2002,30:42-48.
  • 8Le Blanc K,Rasmusson I,Sundberg B,et al.Treatment ofsevere acute graft-versus-host disease with third party hap- loidentical mesenchymal stem cells[J].Lancet,2004,363:1439-1441.
  • 9Fang B,Liao L,Shi M,et al.Multipotency of Flk1CD34progenitors derived from human fetal bone marrow[J].JLab Clin Med,2004,143:230-240.
  • 10Deng W,Han Q,Liao L,et al.Allogeneic bone marrow-derived flk-1+Sca-1-mesenchymal stem cells leads tostable mixed chimerism and donor-specific tolerance[J].Exp Hematol,2004,32:861-867.

同被引文献125

  • 1肖斌,刘毅,于晟,陈绍宗,张绪生,田文艳.脂肪颗粒组织在不同冻存条件下低温保护剂的筛选[J].中国美容医学,2005,14(4):397-399. 被引量:7
  • 2Pittenger MF, Mackay AM, Beck SC,et al. Muhilineage potential of a- dult human mesenchymal stem cells [ J ]. Science, 1999,284 (541) : 143- 147.
  • 3Gronthos S, Franklin DM, Leddy HA, et al. Surface protein character- ization of human adipose tissue derived stromal cells[ J]. J Cell Physiol, 2001,189( 1 ) :54-63.
  • 4Campagnoli C, Roberts IA, Kumar S, et al. Identification of mesenchy- real stem/progenitor cells in human first-trimester fetal blood, liver, and hone marrow[ J ]. Blood ,2001,98 (8) :2396-2402.
  • 5Igura K, Zhang X, Takahashi K, et al. Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta[ J ]. Cytotherapy ,2004,6 (6) :543-553.
  • 6Tocei A, Forte L. Mesenehymal stem cells: use and perspectives [ J ]. HenatolJ, 2003,4 ( 2 ) :92 -96.
  • 7Horwitz EM, Gordon PL, Koo WK, et al. Isolated allogeneic bone mar- row-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone [ J ]. Pmc Natl Acad Sci USA,2002,99(13) :8932-8937.
  • 8Kosc ON, Gerson SL, Cooper BW, et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients re- ceiving high-dose chemotherapy [ J ]. J Cli Oncol, 2000, 18 ( 2 ) : 307-316.
  • 9Noon WA, Kruisselbrink AB, Anker PS, et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34+ cells in NOD/SCID mice[ J]. Exp Hematol,2002,30 ( 8 ) :870-878.
  • 10Anker PS, Noort WA, Kruisselbrink AB, et al. Nonexpanded primary lung bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34+ cells NOD/SCID mice [ J ]. Exp He- matol ,2003,31 (10) :881-889.

引证文献7

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部